Hochschulschrift
Pharmacokinetic, Pharmacodynamic : modeling and simulation of biomarker response to venlafaxine and sunitinib administration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
25 cm
- Umfang
-
IV, 165 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Bonn, Univ., Diss., 2011 (Nicht für den Austausch)
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Lindauer, Andreas
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:11 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Lindauer, Andreas
Ähnliche Objekte (12)
Pharmacokinetic, Pharmacodynamic Modeling and Simulation of Biomarker Response to Venlafaxine and Sunitinib Administration
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integration of pharmacokinetic and intracellular models of interferon administration and induced responses
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Population pharmacokinetic modeling to understand antineoplastic treatment
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development and Research: Methodology, Applications, and Limitations
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Monitoring of propofol in breath; pharmacokinetic modeling and design of a control system
Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response
Effect of drugs on the cardiac transport, metabolism and action of idarubicin : pharmacokinetic and pharmacodynamic modeling
Pharmacokinetic, Pharmacodynamic Modeling and Simulation of Biomarker Response to Venlafaxine and Sunitinib Administration
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integration of pharmacokinetic and intracellular models of interferon administration and induced responses
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Population pharmacokinetic modeling to understand antineoplastic treatment
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development and Research: Methodology, Applications, and Limitations
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Monitoring of propofol in breath; pharmacokinetic modeling and design of a control system
Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response
Effect of drugs on the cardiac transport, metabolism and action of idarubicin : pharmacokinetic and pharmacodynamic modeling
Pharmacokinetic, Pharmacodynamic Modeling and Simulation of Biomarker Response to Venlafaxine and Sunitinib Administration
Development of a Combined Pharmacokinetic Model for Lacosamide and its Metabolite for Integrated Pharmacokinetic Modeling in Humans
Integration of pharmacokinetic and intracellular models of interferon administration and induced responses
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Population pharmacokinetic modeling to understand antineoplastic treatment
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development and Research: Methodology, Applications, and Limitations
Translational physiologically-based pharmacokinetic (PBPK) modeling and simulation to support drug development and pharmacotherapy
Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping
Monitoring of propofol in breath; pharmacokinetic modeling and design of a control system
Effects of pharmacokinetic gene variation on therapeutic drug levels and antidepressant treatment response